ロード中...
Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
Resveratrol (RSV) is a potential alternative therapy for non-alcoholic fatty liver disease (NAFLD) that has been evaluated in many clinical trials, but the mechanisms of RSV action have not been fully elucidated. Recent studies suggested that the gut microbiota is an important RSV target; therefore,...
保存先:
| 出版年: | Front Microbiol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7942199/ https://ncbi.nlm.nih.gov/pubmed/33708180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2021.611323 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|